Julie G Frank - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Plos One|May 10, 2012

Synaptic and intrinsic activation of GABAergic neurons in the cardiorespiratory brainstem networkJulie G Frank, David Mendelowitz

Synapse (New York, N.Y.)|February 8, 2006

In vitro regulation of serotonin transporter activity by protein kinase A and nicotinic acetylcholine receptors in the prefrontal cortex of ratsTammy L Awtry, Julie G Frank, Linda L Werling

Experimental Neurology|August 11, 2007

A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorderLinda L Werling, Ashleigh Keller, Julie G Frank, et al.

Developmental Psychobiology|December 29, 2005

Serial reversal learning of position discrimination in developing ratsDeborah J Watson, Jesse R Sullivan, Julie G Frank, et al.

Molecular Cancer Therapeutics|September 7, 2019

First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast CancerAnna Capasso, Stacey M Bagby, Kyrie L Dailey, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Plos One|May 10, 2012

Synaptic and intrinsic activation of GABAergic neurons in the cardiorespiratory brainstem networkJulie G Frank, David Mendelowitz

Synapse (New York, N.Y.)|February 8, 2006

In vitro regulation of serotonin transporter activity by protein kinase A and nicotinic acetylcholine receptors in the prefrontal cortex of ratsTammy L Awtry, Julie G Frank, Linda L Werling

Experimental Neurology|August 11, 2007

A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: treatment of involuntary emotional expression disorderLinda L Werling, Ashleigh Keller, Julie G Frank, et al.

Developmental Psychobiology|December 29, 2005

Serial reversal learning of position discrimination in developing ratsDeborah J Watson, Jesse R Sullivan, Julie G Frank, et al.

Molecular Cancer Therapeutics|September 7, 2019

First-in-Class Phosphorylated-p68 Inhibitor RX-5902 Inhibits β-Catenin Signaling and Demonstrates Antitumor Activity in Triple-Negative Breast CancerAnna Capasso, Stacey M Bagby, Kyrie L Dailey, et al.

Pageof 1